Glaxo Wellcome Inc. v. United States

126 F. Supp. 2d 581, 24 Ct. Int'l Trade 1408, 24 C.I.T. 1408, 22 I.T.R.D. (BNA) 2426, 2000 Ct. Intl. Trade LEXIS 168
CourtUnited States Court of International Trade
DecidedDecember 21, 2000
DocketSlip Op. 00-167; Court 96-07-01792
StatusPublished
Cited by1 cases

This text of 126 F. Supp. 2d 581 (Glaxo Wellcome Inc. v. United States) is published on Counsel Stack Legal Research, covering United States Court of International Trade primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Glaxo Wellcome Inc. v. United States, 126 F. Supp. 2d 581, 24 Ct. Int'l Trade 1408, 24 C.I.T. 1408, 22 I.T.R.D. (BNA) 2426, 2000 Ct. Intl. Trade LEXIS 168 (cit 2000).

Opinion

*584 OPINION AND ORDER

WATSON, Senior Judge.

INTRODUCTION

Plaintiff, Glaxo Wellcome Inc. (“Glaxo”), a leading research-based pharmaceutical company and importer of pharmaceutical products from the United Kingdom, challenges the assessment of duty upon liquidation of its three entries by the United States Customs Service (“Customs”) under subheading 3004.90.60 of the Harmonized Tariff Schedule of the United States (“HTSUS”) at the rate of 6.3 percent ad valorem. The latter rate was in effect on December 28, 1994 when plaintiff entered its merchandise for immediate transportation (“I.T.”) at the Port of Norfolk, Virginia to the Port of Durham, North Carolina.

Plaintiff claims that its entries should have been liquidated by Customs duty-free under subheading 3004.90.90, HTSUS, a reduced duty rate and new HTSUS subheading that was put into effect with respect to the subject merchandise entered for consumption or withdrawn from warehouse for consumption on and after January 1, 1995 pursuant to Presidential Proclamation 6763 (“Proclamation”). Glaxo’s pharmaceuticals were entered for consumption on January 3, 1995 at the destination Port of Durham, North Carolina. Thus, after plaintiffs merchandise was entered for I.T. at Norfolk on December 28, 1994, the Proclamation became “effective with respect to goods entered or withdrawn from warehouse for consumption on and after January 1, 1995,” and reduced the duty rate to zero percent on plaintiffs pharmaceuticals (hereinafter referred to as the Proclamation’s “effective date provision”). 60 Fed.Reg. at 1009.

The gravamen of plaintiffs complaint is that notwithstanding that its merchandise had been entered for immediate transportation on December 28, 1994, since the subject merchandise was entered for consumption on January 3,1995, the merchandise qualified for the duty-free (zero) rate of duty then in effect under subheading 3004.90.90, pursuant to Proclamation 6763.

The dispute in this case is the applicable subheading under the HTSUS and the rate of duty for plaintiffs goods, and therefore, this action is before the court pursuant to its jurisdiction under 19 U.S.C. § 1581(a). Before the court are the parties’ cross-motions for summary judgment pursuant to USCIT Rule 56. The court finds there is no genuine issue of material fact and this case may be resolved by summary judgment. USCIT R. 56(d); Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 247, 106 S.Ct. 2505, 91 L.Ed.2d 202 (1986).

STATUTE INVOLVED

The statutory provision the Government claims is determinative of the applicable rate of duty on plaintiffs 1994 entries for immediate transportation, 19 U.S.C. § 1315(a)(2), reads:

§ 1315. Effective date of rates of duty
(a) Articles entered or withdrawn from warehouse for consumption
Except as otherwise specially provided for, the rate or rates of duty imposed by or pursuant to this chapter or any other law on any article entered for consumption or withdrawn from warehouse for consumption shall be the rate or rates in effect when the documents comprising the entry for consumption or withdrawal from warehouse for consumption and any estimated or liquidated duties then required to be paid have been deposited with the Customs Service * * *, except that
$ ‡ ‡ ‡ $
(2) any article which is not subject to a quantitative or tariff rate quota and which is covered by an entry for immediate transportation made at the port of original importation under section 1552 of this title, if entered for consumption at the port designated by the consignee, or his agent, in such *585 transportation entry without having been taken into the custody of the appropriate customs officer under section 1490 of this title, shall be subject to the rate or rates in effect when the transportation entry was accepted at the port of original importation;

See also: 19 C.F.R. §§ 141.69, 152.17 (changes in duty rates by Presidential Proclamations are subject to the provisions of § 141.69, including the exception under subsection (b) for I.T. entries).

THE RECORD

The evidentiary record before the court on the cross-motions comprises of a stipulation of facts, copies of Customs’ administrative messages in dispute, Customs’ ruling letters, an affidavit of a Customs official submitted by defendant, and other documentary evidence. Plaintiff takes exception to the affidavit submitted by defendant.

The following comments are intended to obviate most of plaintiffs objections to defendant’s affidavit, which are without merit.

While motions for summary judgment may be submitted for decision solely on stipulated facts, the stipulated facts before the court do not provide that the action is submitted solely on the stipulated facts. Accordingly, defendant was entitled to, and did, submit an affidavit, which is explicitly permissible in summary judgment practice under USCIT Rule 56.

If a party submits an affidavit in support of or in opposition to a motion for summary judgment, the form of the affidavit must comply with Rule 56(e), which includes the requirement that it be made on personal knowledge, shall set forth facts that would be admissible in evidence, and shall show affirmatively that the affiant is competent to testify as to the matters stated therein. Id. If the foregoing requirements are met, an affidavit is an acceptable form of evidence under Rule 56(e), and the credibility of the affiant or veracity of the averments are not issues that may be resolved on summary judgment. However, the facts averred in an affidavit may be disputed by an opposing affidavit, a deposition, or answers to interrogatories, Rule 56(e), in which event, the case must proceed to trial to resolve genuine issues of material fact. Finally, Rule 56 does not require that a party give prior notice to the other party that an affidavit will be submitted in support of or in opposition to a motion for summary judgment.

The court turns to plaintiffs substantive objections to the content of the affidavit. Defendant’s affiant is Ms. Vera Adams, the Director of the Commercial Processing Division, Office of Trade Programs (formerly called the Office of Trade Operations), a position she had held since approximately June 1998. Prior to this position, Adams was a former Import Specialist in St. Louis, Missouri and New Orleans, LA., and a supervisor of the entry divisions in Memphis, TN and New Orleans, LA.

Ms.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Xerox Corp. v. United States
219 F. Supp. 2d 1345 (Court of International Trade, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
126 F. Supp. 2d 581, 24 Ct. Int'l Trade 1408, 24 C.I.T. 1408, 22 I.T.R.D. (BNA) 2426, 2000 Ct. Intl. Trade LEXIS 168, Counsel Stack Legal Research, https://law.counselstack.com/opinion/glaxo-wellcome-inc-v-united-states-cit-2000.